Clinical TrialsSearch results
Number of results: 778
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- The safety and efficacy trial of primary chemo-radiotherapy for stage I to IIIA breast cancer (JCOG0306)
- stage I to IIIA breast cancer
- Japan Clinical Oncology Group
- 2005-09-05
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30
Other
- Double-blind Placebo-controlled Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
- Spinal and Bulbar Muscular Atrophy(SBMA)
- Center for Clinical Trials, Japan Medical Association
- 2006-09-05
Other
- Long Term Follow-up Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
- Spinal and Bulbar Muscular Atrophy (SBMA)
- Department of Neurology, Nagoya University School of Medicine
- 2008-02-01
Recruiting
- Effective physical assessment in ITB screening trials
- Spastic paraplegia, myelitis, multiple sclerosis, cerebrovascular disease, etc.
- Murata Atsushi
- 2023-04-07
Recruiting
- Rsecue in cogunitive behavioral family therapy
- somatic symtom disorder with predominant pain
- Shimizu Eiji
- 2021-08-16
Recruiting
- cognitive behaviolral familly therapy for chronic pain
- somatic symptom disorder with predominant pain
- Shimizu Eiji
- 2021-02-09
Completed
- Imagery rescripting for Chronic Pain
- somatic symptom disorder with predominant pain
- Shimizu Eiji
- 2021-03-25
Recruiting
- Phase I/II Study of the Selective RET Inhibitor TAS0953/HM06 in Patients with Advanced Solid Tumors with RET gene abnormalities
- Solid tumor (Non-small cell lung cancer, and so on)
- Masuda Noriyuki
- 2020-11-23